<DOC>
	<DOCNO>NCT01001052</DOCNO>
	<brief_summary>The purpose study evaluate compare relative bioavailability single dose Colcrys™ ( colchicine ) 0.6 mg administer group young , healthy subject 18-30 year age compare group older , generally healthy subject 60 year age old follow overnight fast .</brief_summary>
	<brief_title>Relative Bioavailability Colcrys™ 0.6 mg Tablets Healthy Young Elderly Volunteers Under Fasted Conditions</brief_title>
	<detailed_description>The purpose study evaluate compare relative bioavailability single dose Colcrys™ ( colchicine ) 0.6 mg administer group young , healthy subject 18-30 year age compare group older , generally healthy subject 60 year age old follow overnight fast . On study Day 1 follow overnight fast , twenty healthy , non-smoking , non-obese male female subject age 18 30 twenty generally healthy , non-smoking , non-obese male female subject 60 year age administer one single dose Colcrys™ ( 1 x 0.6 mg tablet ) . Fasting continue 4 hour dose . Blood sample draw participant dose 24 hour post-dose confined basis time sufficient adequately define pharmacokinetics Colcrys . Blood sample continue non-confined basis 36 , 48 , 60 72 hour post-dose . Subjects monitor throughout participation study adverse reaction study drug and/or procedure . Vitals sign ( temperature , respiratory rate , pulse rate blood pressure ) measure sit position prior dose . Seated blood pressure pulse measure approximately 1 , 3 , 6 12 hour dose prior release facility . All adverse event whether elicited query , spontaneously report , observe clinic staff evaluate Investigator report subject 's case report form .</detailed_description>
	<mesh_term>Colchicine</mesh_term>
	<criteria>Healthy adult 1830 year age generally healthy adult 60 year age ( elderly subject minor renal impairment may allow participate discretion investigator ) , nonsmoking nonpregnant ( postmenopausal , surgically sterile use effective contraceptive measure ) body mass index ( BMI ) 1830 kg/m2 . Recent participation ( within 30 day ) research study Recent significant blood donation plasma donation Pregnant lactate Test positive screening human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HbsAg ) , hepatitis C virus ( HCV ) History treatment drug alcohol addiction within previous 12 month excessive alcohol consumption past 12 month Significant history chronic infectious disease , system disorder , organ dysfunction , especially cardiovascular disorder ( angina , heart failure , irregular heartbeat , heart attack , hypertension , hypotension ) stroke , renal hepatic disorder , diabetes bleed disorder , gastrointestinal disease psychiatric disorder . Presence medical condition require regular treatment prescription drug Subjects use drug substance know inhibit induce drugmetabolizing enzyme within 30 day prior first dose throughout study Drug allergy sensitivity colchicine Positive test result drug abuse screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Healthy</keyword>
	<keyword>bioavailability</keyword>
</DOC>